FGF21 attenuates pulmonary fibrogenesis through ameliorating oxidative stress in vivo and in vitro
Authors:
- 1 July 2018
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 103, 1516-1525
Abstract
No abstract availableKeywords
Funding Information
- National Key R&D Program of China (2016YFD0501003)
- National Key R&D Program of China (2017YFD0501102)
- National Key R&D Program of China (2017YFD0501103-03)
- Science and Technology Planning Program of Heilongjiang Province (GC13C104)
This publication has 43 references indexed in Scilit:
- Thymoquinone blocks lung injury and fibrosis by attenuating bleomycin-induced oxidative stress and activation of nuclear factor Kappa-B in ratsToxicology, 2012
- Oxidative stress in health and disease: The therapeutic potential of Nrf2 activationMolecular Aspects of Medicine, 2011
- Oxidative stress: acute and progressive lung injuryAnnals of the New York Academy of Sciences, 2010
- Oxidative stress and glutathione in TGF-β-mediated fibrogenesisFree Radical Biology and Medicine, 2010
- Paraquat Poisonings: Mechanisms of Lung Toxicity, Clinical Features, and TreatmentCritical Reviews in Toxicology, 2008
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007
- Bleomycin lung toxicity: who are the patients with increased risk?Pulmonary Pharmacology & Therapeutics, 2005
- Oxidative Stress in Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2005
- FGF-21 as a novel metabolic regulatorJournal of Clinical Investigation, 2005
- Superoxide Dismutases in the Lung and Human Lung DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 2003